Tag: vascular trauma
Human-tissue engineered blood vessels remain durable at six years in PAD...
Mid-term results from a phase II study of surgical bypass using the Human Acellular Vessel (HAV; Humacyte) demonstrated an overall secondary patency rate at...
Systemic heparin during TEVAR deemed safe for selected traumatic brain injury...
The use of systemic heparin during thoracic endovascular aneurysm repair (TEVAR) for blunt thoracic aortic injuries (BTAI) appears to be safe in selected patients...
Humacyte provides update on patients treated at front-line hospitals in Ukraine...
Humacyte today announced that the first Ukrainian patients have received implants of the Human Acellular Vessel (HAV) for the treatment of vascular trauma injuries....
CX returns to in-person format once more in the London spring
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, due to be held 26–28 April in London, UK, and...
Study indicates increasing vascular surgeon involvement in trauma cases
Fifteen years’ worth of data from a major US trauma centre suggest that the involvement of vascular surgeons in trauma management has increased over...
Endovascular resuscitation and trauma management: Vascular surgeons and interventionalists should take...
In the last 20 years, there have been major developments in the use of endovascular and hybrid haemorrhage control tools, especially in the treatment...
Humacyte commences phase II vascular trauma trial
Humacyte has announced the initiation of a US phase II vascular trauma clinical trial of Humacyl, its investigational human acellular vessel, for vascular replacement...
